Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
February 2013 Volume 5 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February 2013 Volume 5 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Identification of MXRA5 as a novel biomarker in colorectal cancer

  • Authors:
    • Guang-Hui Wang
    • Ling Yao
    • Hong-Wei Xu
    • Wen-Tao Tang
    • Ji‑Hong Fu
    • Xiao-Fang Hu
    • Long Cui
    • Xue-Min Xu
  • View Affiliations / Copyright

    Affiliations: Colorectal Surgery Department, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, P.R. China, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200092, P.R. China, Department of Gastroenterology, Kunshan Hospital of Traditional Chinese Medicine, Jiangsu 215300, P.R. China, School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai 200092, P.R. China
  • Pages: 544-548
    |
    Published online on: November 21, 2012
       https://doi.org/10.3892/ol.2012.1038
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

In our previous study, significantly high expression levels of matrix-remodeling associated 5 (MXRA5) were identified in fresh-cultured colorectal cancer (CRC) tissues compared with their normal adjacent mucosa by differential secretome analysis. Whether MXRA5 is a potential serum biomarker of CRC has not been evaluated. The aim of this study was to investigate the association between MXRA5 expression and clinicopathological characteristics of CRC patients. The MXRA5 expression levels were determined by quantitative real-time PCR (qRT‑PCR) and immunohistochemistry (IHC) in 20 colorectal adenoma tissues, 156 CRC tissues and their corresponding adjacent normal mucosa. Relative quantity (RQ) value and immunoreactive score (IRS) were used for quantitative assessment. The staining for MXRA5 protein was mainly located in the cytoplasm of CRC cells. All CRC tissues were positively stained, with a higher expression rate (IRS>4) of 67% (105/156), and a lower expression rate (IRS≤4) of 33% (51/156). Meanwhile, their corresponding normal tissues exhibited little positive staining; the higher expression rate was 0% (0/156) and the lower expression rate was 25% (16/156). Additionally, more than half of the adenoma tissues were positively stained; the higher expression rate was 15% (3/20) and the lower expression rate was 50% (10/20). The MXRA5 protein positive staining rates were significantly correlated with the lesion sites (colon vs. rectum, 76 vs. 59%), TNM staging (I+II vs. III+IV, 56 vs. 73%) and metastasis (present vs. absent; 76 vs. 61%) with the most high positive staining rate observable in omental metastasis (82%). However, MXRA5 mRNA expression levels showed no significant differences between CRC tissues and their corresponding normal tissues, and no significant correlation between IRS and corresponding RQ value was observed. In this study, we present the first evaluation of MXRA5 protein expression in CRC tissue. Our results revealed that MXRA5 protein is aberrantly expressed in CRC tissues, and has potential value in early detection of CRC and prediction of omental metastasis.
View Figures

Figure 1

Figure 2

Figure 3

View References

1. 

Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI

2. 

Ross JS: Biomarker update for breast, colorectal and non-small cell lung cancer. Drug News Perspect. 23:82–88. 2010. View Article : Google Scholar : PubMed/NCBI

3. 

Bast RC Jr, Ravdin P, Hayes DF, et al: 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 19:1865–1878. 2001.PubMed/NCBI

4. 

Duffy M, Van Dalen A, Haglund C, et al: Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer. 43:1348–1360. 2007. View Article : Google Scholar : PubMed/NCBI

5. 

Wang Q, Zhang YN, Lin GL, et al: S100P, a potential novel prognostic marker in colorectal cancer. Oncol Rep. 28:303–310. 2012.

6. 

Higashijima J, Kurita N, Miyatani T, et al: Expression of histone deacetylase 1 and metastasis-associated protein 1 as prognostic factors in colon cancer. Oncol Rep. 26:343–348. 2011.PubMed/NCBI

7. 

Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I and Kerr D: Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer. 9:489–499. 2009. View Article : Google Scholar : PubMed/NCBI

8. 

Siena S, Sartore-Bianchi A, Di Nicolantonio F, Balfour J and Bardelli A: Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. J Natl Cancer Inst. 101:1308–1324. 2009. View Article : Google Scholar : PubMed/NCBI

9. 

Helgason HH, Engwegen JY, Zapatka M, et al: Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry. Oncol Rep. 24:57–64. 2010. View Article : Google Scholar

10. 

Chung CH, Seeley EH, Roder H, et al: Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patients. Cancer Epidemiol Biomarkers Prev. 19:358–365. 2010. View Article : Google Scholar : PubMed/NCBI

11. 

Sun W, Xing B, Sun Y, et al: Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues. Mol Cell Proteomics. 6:1798–1808. 2007. View Article : Google Scholar

12. 

Phizicky E, Bastiaens PI, Zhu H, Snyder M and Fields S: Protein analysis on a proteomic scale. Nature. 422:208–215. 2003. View Article : Google Scholar : PubMed/NCBI

13. 

Yao L, Lao W, Zhang Y, et al: Identification of EFEMP2 as a serum biomarker for the early detection of colorectal cancer with lectin affinity capture assisted secretome analysis of cultured fresh tissues. J Proteome Res. Apr 30–2012.(Epub ahead of print).

14. 

Olski TM, Noegel AA and Korenbaum E: Parvin, a 42 kDa focal adhesion protein, related to the alpha-actinin superfamily. J Cell Sci. 114:525–538. 2001.PubMed/NCBI

15. 

Lozada C, Levin RI, Huie M, et al: Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1. Proc Natl Acad Sci USA. 92:8378–8382. 1995. View Article : Google Scholar

16. 

Walker MG and Volkmuth W: Cell adhesion and matrix remodeling genes identified by co-expression analysis. Gene Function & Disease. 3:109–112. 2002.

17. 

Alsner J, Rødningen OK and Overgaard J: Differential gene expression before and after ionizing radiation of subcutaneous fibroblasts identifies breast cancer patients resistant to radiation-induced fibrosis. Radiother Oncol. 83:261–266. 2007. View Article : Google Scholar

18. 

Rødningen OK, Børresen-Dale AL, Alsner J, Hastie T and Overgaard J: Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis. Radiother Oncol. 86:314–320. 2008.PubMed/NCBI

19. 

Chondrogianni N, de C M Simoes D, Franceschi C and Gonos ES: Cloning of differentially expressed genes in skin fibroblasts from centenarians. Biogerontology. 5:401–409. 2004. View Article : Google Scholar : PubMed/NCBI

20. 

Buckanovich RJ, Sasaroli D, O’Brien-Jenkins A, et al: Tumor vascular proteins as biomarkers in ovarian cancer. J Clin Oncol. 25:852–861. 2007. View Article : Google Scholar : PubMed/NCBI

21. 

Zou TT, Selaru FM, Xu Y, et al: Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene. 21:4855–4862. 2002. View Article : Google Scholar : PubMed/NCBI

22. 

Sompayrac SW, Mindelzun RE, Silverman PM and Sze R: The greater omentum. AJR Am J Roentgenol. 168:683–687. 1997. View Article : Google Scholar : PubMed/NCBI

23. 

Kehinde E, Abdeen S, Al-Hunayan A and Ali Y: Prostate cancer metastatic to the omentum. Scand J Urol Nephrol. 36:225–227. 2002. View Article : Google Scholar : PubMed/NCBI

24. 

Chou CK, Liu GC, Su JH, Chen LT, Sheu RS and Jaw TS: MRI demonstration of peritoneal implants. Abdom Imaging. 19:95–101. 1994. View Article : Google Scholar : PubMed/NCBI

25. 

Levitt RG, Koehler RE, Sagel SS and Lee JK: Metastatic disease of the mesentery and omentum. Radiol Clin North Am. 20:501–510. 1982.PubMed/NCBI

26. 

Silverman P and Cooper C: Mesenteric and omental lesions. Textbook of Gastrointestinal Radiology. 1st edition. WB Saunders; Philadelphia, PA: 1994

27. 

Fujiwara H, Saga Y, Takahashi K, et al: Omental metastases in clinical stage I endometrioid adenocarcinoma. Int J Gynecol Cancer. 18:165–167. 2008. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang G, Yao L, Xu H, Tang W, Fu JH, Hu X, Cui L and Xu X: Identification of MXRA5 as a novel biomarker in colorectal cancer. Oncol Lett 5: 544-548, 2013.
APA
Wang, G., Yao, L., Xu, H., Tang, W., Fu, J., Hu, X. ... Xu, X. (2013). Identification of MXRA5 as a novel biomarker in colorectal cancer. Oncology Letters, 5, 544-548. https://doi.org/10.3892/ol.2012.1038
MLA
Wang, G., Yao, L., Xu, H., Tang, W., Fu, J., Hu, X., Cui, L., Xu, X."Identification of MXRA5 as a novel biomarker in colorectal cancer". Oncology Letters 5.2 (2013): 544-548.
Chicago
Wang, G., Yao, L., Xu, H., Tang, W., Fu, J., Hu, X., Cui, L., Xu, X."Identification of MXRA5 as a novel biomarker in colorectal cancer". Oncology Letters 5, no. 2 (2013): 544-548. https://doi.org/10.3892/ol.2012.1038
Copy and paste a formatted citation
x
Spandidos Publications style
Wang G, Yao L, Xu H, Tang W, Fu JH, Hu X, Cui L and Xu X: Identification of MXRA5 as a novel biomarker in colorectal cancer. Oncol Lett 5: 544-548, 2013.
APA
Wang, G., Yao, L., Xu, H., Tang, W., Fu, J., Hu, X. ... Xu, X. (2013). Identification of MXRA5 as a novel biomarker in colorectal cancer. Oncology Letters, 5, 544-548. https://doi.org/10.3892/ol.2012.1038
MLA
Wang, G., Yao, L., Xu, H., Tang, W., Fu, J., Hu, X., Cui, L., Xu, X."Identification of MXRA5 as a novel biomarker in colorectal cancer". Oncology Letters 5.2 (2013): 544-548.
Chicago
Wang, G., Yao, L., Xu, H., Tang, W., Fu, J., Hu, X., Cui, L., Xu, X."Identification of MXRA5 as a novel biomarker in colorectal cancer". Oncology Letters 5, no. 2 (2013): 544-548. https://doi.org/10.3892/ol.2012.1038
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team